Joaquina Mauricio

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Expression of ENPP1 in Testicular Germ Cell Tumors: Exploring Its Role in the Pathobiology of Distinct Histotypes and in Prognosis.

Expression of ENPP1 in Testicular Germ Cell Tumors: Exploring Its Role in the Pathobiology of Distinct Histotypes and in Prognosis.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: April 22, 2025

MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors.

MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors.

Journal: Cell communication and signaling : CCS

Published: March 30, 2025

Short Hydration Regimen in Cisplatin-Based Chemotherapy and Its Impact on Nephrotoxicity: A Unicentric Prospective Study.

Short Hydration Regimen in Cisplatin-Based Chemotherapy and Its Impact on Nephrotoxicity: A Unicentric Prospective Study.

Journal: Cureus

Published: February 27, 2025

Differential expression of metabolic enzymes in testicular germ cell tumors: The impact of glycolytic metabolism in embryonal carcinoma histotype.

Differential expression of metabolic enzymes in testicular germ cell tumors: The impact of glycolytic metabolism in embryonal carcinoma histotype.

Journal: Andrology

Published: October 24, 2024

Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review.

Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review.

Journal: Cureus

Published: June 29, 2024

EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.

EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.

Journal: Andrology

Published: October 11, 2023

DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.

DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.

Journal: Frontiers in oncology

Published: February 15, 2022

Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm.

Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm.

Journal: Life (Basel, Switzerland)

Published: January 28, 2022

AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes.

AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes.

Journal: Pharmacogenomics

Published: October 21, 2021

The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.

The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 27, 2021

Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.

Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.

Journal: Clinical epigenetics

Published: December 31, 2020

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.

Journal: Molecular oncology

Published: November 29, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026